In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price...
TrustPilot
vor 2 Monaten
vor 2 Wochen
vor 1 Woche
vor 2 Wochen